These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Human defensin alpha-1 causes Trypanosoma cruzi membrane pore formation and induces DNA fragmentation, which leads to trypanosome destruction. Madison MN; Kleshchenko YY; Nde PN; Simmons KJ; Lima MF; Villalta F Infect Immun; 2007 Oct; 75(10):4780-91. PubMed ID: 17635867 [TBL] [Abstract][Full Text] [Related]
6. Unmethylated CpG motifs in Toxoplasma gondii DNA induce TLR9- and IFN-β-dependent expression of α-defensin-5 in intestinal epithelial cells. Santamaria MH; Perez Caballero E; Corral RS Parasitology; 2016 Jan; 143(1):60-8. PubMed ID: 26522645 [TBL] [Abstract][Full Text] [Related]
7. Metacytofilin Is a Potent Therapeutic Drug Candidate for Toxoplasmosis. Leesombun A; Iijima M; Umeda K; Kondoh D; Pagmadulam B; Abdou AM; Suzuki Y; Ohba SI; Isshiki K; Kimura T; Kubota Y; Sawa R; Nihei CI; Nishikawa Y J Infect Dis; 2020 Feb; 221(5):766-774. PubMed ID: 31573038 [TBL] [Abstract][Full Text] [Related]
8. Dynamin inhibitor impairs Toxoplasma gondii invasion. Caldas LA; Attias M; de Souza W FEMS Microbiol Lett; 2009 Nov; 301(1):103-8. PubMed ID: 19817867 [TBL] [Abstract][Full Text] [Related]
9. In vitro antagonistic and indifferent activity of combination of 3-deoxyanthocyanidins against Toxoplasma gondii. Abugri DA; Witola WH; Jaynes JM Parasitol Res; 2017 Dec; 116(12):3387-3400. PubMed ID: 29086004 [TBL] [Abstract][Full Text] [Related]
10. Discovery of New Inhibitors of Toxoplasma gondii via the Pathogen Box. Spalenka J; Escotte-Binet S; Bakiri A; Hubert J; Renault JH; Velard F; Duchateau S; Aubert D; Huguenin A; Villena I Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133550 [No Abstract] [Full Text] [Related]
11. Direct and Indirect Inhibition Effects of Resveratrol against Chen QW; Dong K; Qin HX; Yang YK; He JL; Li J; Zheng ZW; Chen DL; Chen JP Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30530601 [No Abstract] [Full Text] [Related]
12. Effect of nitaxozanide and pyrimethamine on astrocytes infected by Toxoplasma gondii in vitro. Galván-Ramírez Mde L; Dueñas Jiménez JM; Rocío Rodríguez Pérez L; Troyo-Sanroman R; Ramírez-Herrera M; García-Iglesias T Arch Med Res; 2013 Aug; 44(6):415-21. PubMed ID: 23973195 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of Huffman AM; Ayariga JA; Napier A; Robertson BK; Abugri DA Front Cell Infect Microbiol; 2022; 12():852889. PubMed ID: 35646733 [No Abstract] [Full Text] [Related]
14. Cellular response to Trypanosoma cruzi infection induces secretion of defensin α-1, which damages the flagellum, neutralizes trypanosome motility, and inhibits infection. Johnson CA; Rachakonda G; Kleshchenko YY; Nde PN; Madison MN; Pratap S; Cardenas TC; Taylor C; Lima MF; Villalta F Infect Immun; 2013 Nov; 81(11):4139-48. PubMed ID: 23980110 [TBL] [Abstract][Full Text] [Related]
15. Effects of PERK eIF2α Kinase Inhibitor against Toxoplasma gondii. Augusto L; Martynowicz J; Staschke KA; Wek RC; Sullivan WJ Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30181373 [No Abstract] [Full Text] [Related]
16. Synthesis, in vitro and in vivo biological evaluation of dihydroartemisinin derivatives with potential anti-Toxoplasma gondii agents. Deng H; Huang X; Jin C; Jin CM; Quan ZS Bioorg Chem; 2020 Jan; 94():103467. PubMed ID: 31791681 [TBL] [Abstract][Full Text] [Related]
17. Afatinib Reduces STAT6 Signaling of Host ARPE-19 Cells Infected with Toxoplasma gondii. Yang Z; Ahn HJ; Park YH; Nam HW Korean J Parasitol; 2016 Feb; 54(1):31-8. PubMed ID: 26951976 [TBL] [Abstract][Full Text] [Related]
18. Derivatives of a benzoquinone acyl hydrazone with activity against Toxoplasma gondii. Sanford AG; Schulze TT; Potluri LP; Watson GF; Darner EB; Zach SJ; Hemsley RM; Wallick AI; Warner RC; Charman SA; Wang X; Vennerstrom JL; Davis PH Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):488-492. PubMed ID: 30500526 [TBL] [Abstract][Full Text] [Related]
19. Toxoplasma gondii as a Model of In Vivo Host-Parasite Interactions. Coutermarsh-Ott S Methods Mol Biol; 2019; 1960():237-247. PubMed ID: 30798537 [TBL] [Abstract][Full Text] [Related]